EBV BMLF-1 280-288 (HLA-A*02:01) GLCTLVAML
Advantages at a glance
- High-quality products
- Customized solutions
- Personal contact
- Fast service
- Competent technical support +49(0)731-3608-123
Quantity | Unit price |
---|---|
To 2 |
€210.00*
|
From 3 |
€157.50*
€210.00*
(25% saved)
|
Product number:
P2295.9505
Delivery time: 3- 8 working days
For detailed information on the delivery date, please contact Genaxxon.
Shipment: not cooled. Store at -20°C. For laboratory usage only!
Delivery time: 3- 8 working days
For detailed information on the delivery date, please contact Genaxxon.
Shipment: not cooled. Store at -20°C. For laboratory usage only!
Product information "EBV BMLF-1 280-288 (HLA-A*02:01) GLCTLVAML"
Single peptide (GLCTLVAML) for stimulation of humanEBV BMLF-1(280-288) CD8+ specific CD8+ T-cells.
The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Purities offered: >95%.
T-cell epitopes are presented on the surface of antigen-presenting cells by MHC molecules. T- cell epitopes presented by MHC class I molecules are typically peptides between 8 and 11 amino acids in length and exhibiting MHC-specific sequence motifs.
Specifications:
Purity: >95% (HPLC, ESi-MS)
Sequence: GLCTLVAML
HLA-type: HLA-A*02:01
lyophilized powder
Applikation / Application:
control peptide for stimulation of IFN gamma release from CD8+ T cells
Einheiten / Units:
Quelle / Source:
synthetic
Sicherheits Hinweise / Safety
Klassifizierungen / Classification
eclass-Nr: 32-16-04-09
Documents - Protocols - Downloads :
Here you will find information and further literature. For further documents (certificates with additional lot numbers, safety data sheets in other languages, further product information) please contact Genaxxon biosience at: info@genaxxon.com or phone: +49 731 3608 123.
Documents:
CertificateSpec. Product Description
General Data 1
General Data 2
Category List
Listed below are articles and references, in which the authors trust in the high quality of this Genaxxon product.
Source: NCBI PubMed
Source: NCBI PubMed